Food and Drug Administration, HHS § 50.3 PART 50—PROTECTION OF HUMAN SUBJECTS

First Page		Document Content
Date: 2014-01-30 11:37:23 Medical research Research Clinical research Medical ethics Pharmaceutical industry Food and Drug Administration Investigational device exemption Clinical trial Institutional review board Informed consent Clinical investigator Human subject research		Food and Drug Administration, HHS § 50.3 PART 50—PROTECTION OF HUMAN SUBJECTS Add to Reading List Source URL: publicfiles.jaeb.org Download Document from Source Website File Size: 203,47 KB Share Document on Facebook

	Client Disclosure and Informed Consent DocID: 1vnrO - View Document
	INFORMED CONSENT/PERMISSION FORM FOR EDUCATION TRIPS (Students Under 18 Years ) The Nipissing-Parry Sound Catholic District School Board is arranging a Summer School Physical Education Ice Hockey program Juy 2nd – July DocID: 1vn2S - View Document
	Gewebebank Bern Tel. Voranmeldung auf 23228 ⁭ Informed Consent vorhanden ⁭ Chirurg....................................... Sucher........................................ Zeit (clamping).......................... DocID: 1vj1g - View Document
	INFORMED CONSENT ASSESSMENT FORM URERB Protocol Code: (to be filled out by URERB Secretariat) DocID: 1vj0w - View Document
	Informed Consent Form Checklist (Including Phase 1 Study) This checklist is designed to assist researchers in drafting, and CREC members in reviewing Informed Consent Forms (including Phase 1 Study). The checklist conta DocID: 1v8vO - View Document